AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32401600 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT booster
Number of subjects: 229
Study 32401600 — intervention group
Group type: COMPARATOR
Intervention: MenACWY-PS
Number of subjects: 229
Study 35190495 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional flossing (CFt)
Number of subjects: 60
Study 35190495 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotted floss (KFt)
Number of subjects: 60
Study 35190495 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental brush (IBt)
Number of subjects: 60
Study 35190495 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 32812836 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma self-management support intervention
Number of subjects: 391
Study 36109375 — intervention group
Group type: EXPERIMENTAL
Intervention: Optibond FL (OFL)
Number of subjects: 112
Study 36109375 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (CSE)
Number of subjects: 112
Study 36109375 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal (SB) in etch-and-rinse (ER) mode
Number of subjects: 112
Study 36109375 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal (SB) in self-etch (SE) mode
Number of subjects: 112
Study 36109375 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional self-etch adhesives
Number of subjects: 112
Study 36109375 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal adhesive
Number of subjects: 112
Study 37062416 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel (125 mg/m2 q1w)
Number of subjects: 864
Study 37062416 — intervention group
Group type: COMPARATOR
Intervention: Solvent-based paclitaxel (175 mg/m2 q2w)
Number of subjects: 864
Study 33508354 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste (including 1.2% w/w cocamidopropyl betaine)
Number of subjects: 29
Study 33508354 — intervention group
Group type: COMPARATOR
Intervention: Comparator toothpaste (including tetrasodium pyrophosphate and sodium lauryl sulphate)
Number of subjects: 29
Study 33508354 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste + DI water rinse
Number of subjects: 29
Study 33508354 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparator toothpaste + OJ rinse
Number of subjects: 29
Study 33508354 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothpastes
Number of subjects: 29
Study 32298756 — intervention group
Group type: EXPERIMENTAL
Intervention: Three different formulations of model drug products
Number of subjects: 0
Study 32298756 — intervention group
Group type: EXPERIMENTAL
Intervention: In silico BE simulation studies using the verified PBPK model
Number of subjects: 0
Study 34305238 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of bupivacaine, 3 μg of sufentanil, and 10 μg of dexmedetomidine
Number of subjects: 60
Study 34305238 — intervention group
Group type: COMPARATOR
Intervention: 15 mg of bupivacaine and 3 μg of sufentanil
Number of subjects: 60
Study 34305238 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 32493088 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrostimulation (ES) device
Number of subjects: 72
Study 32493088 — intervention group
Group type: COMPARATOR
Intervention: Sham electrostimulation (SES)
Number of subjects: 72
Study 35790425 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 66
Study 35790425 — intervention group
Group type: COMPARATOR
Intervention: Community weight management intervention
Number of subjects: 66
Study 34190056 — intervention group
Group type: EXPERIMENTAL
Intervention: 600mg Calcium + 400 IU Vitamin D3/day
Number of subjects: 330
Study 34190056 — intervention group
Group type: EXPERIMENTAL
Intervention: 600mg Calcium + 800 IU Vitamin D3/day
Number of subjects: 330
Study 34190056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 32216778 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.454% w/w stannous fluoride dentifrice
Number of subjects: 90
Study 32216778 — intervention group
Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 90
Study 35277045 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation with whey protein and vitamin D (100 kcal; whey protein 10 g; vitamin D 20 µg) twice a day for up to 16 weeks
Number of subjects: 50
Study 35277045 — intervention group
Group type: COMPARATOR
Intervention: Placebo jelly
Number of subjects: 50
Study 35277045 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation with whey protein and vitamin D
Number of subjects: 50
Study 33510477 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteome-wide association study (PWAS) of AD
Number of subjects: 11
Study 33510477 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization and colocalization analysis
Number of subjects: 11
Study 32122856 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and prebiotic fortified flour (various types based on different dosages of prebiotics and iron fortificants)
Number of subjects: 75
Study 32122856 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 75
Study 35027477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 2-chloroprocaine 1% (dose of 27.8 mg estimated ED90 in cohort I and 28 mg in cohort II)
Number of subjects: 90
Study 35027477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 2-chloroprocaine 1%
Number of subjects: 90
Study 34742002 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy - Building Stronger Families (MST-BSF)
Number of subjects: 98
Study 34742002 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive Community Treatment (CCT)
Number of subjects: 98
Study 33138738 — intervention group
Group type: EXPERIMENTAL
Intervention: Board game activities (12 sessions)
Number of subjects: 150
Study 33138738 — intervention group
Group type: COMPARATOR
Intervention: Ordinary activities
Number of subjects: 150
Study 33576415 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Psychosocial Group Treatment (IPGT)
Number of subjects: 30
Study 33576415 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 30
Study 33610076 — intervention group
Group type: EXPERIMENTAL
Intervention: BBTi (n = 32; psychoeducation, sleep hygiene, stimulus control, sleep restriction, relaxation, review/maintenance)
Number of subjects: 62
Study 33610076 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring control (SMC; n = 30; social conversations)
Number of subjects: 62
Study 32584396 — intervention group
Group type: EXPERIMENTAL
Intervention: Savolitinib
Number of subjects: 0
Study 32584396 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study 36072082 — intervention group
Group type: EXPERIMENTAL
Intervention: Happiness training (8 sessions, 60 minutes each)
Number of subjects: 52
Study 36072082 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 52
Study 33373671 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat fit category
Number of subjects: 554
Study 33373671 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfat fit category
Number of subjects: 554
Study 33373671 — intervention group
Group type: COMPARATOR
Intervention: Fat unfit category
Number of subjects: 554
Study 33373671 — intervention group
Group type: COMPARATOR
Intervention: Unfat unfit category
Number of subjects: 554
Study 33373671 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive functions (inhibition, working memory, cognitive flexibility) as mediators
Number of subjects: 554
Study 33122773 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping combined with a six‐week rehabilitation protocol
Number of subjects: 60
Study 33122773 — intervention group
Group type: COMPARATOR
Intervention: Control group (only rehabilitation protocol)
Number of subjects: 60
Study 33122773 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Kinesio Taping and Control)
Number of subjects: 60
Study 35168975 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative autologous blood donation (PABD) in group B (1 week before surgery)
Number of subjects: 1200
Study 35168975 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative autologous blood donation (PABD) in group C (2 weeks before surgery)
Number of subjects: 1200
Study 35168975 — intervention group
Group type: COMPARATOR
Intervention: Control group A (no PABD)
Number of subjects: 1200
Study 35168975 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1200
Study 34148244 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazpiroben 5 mg
Number of subjects: 51
Study 34148244 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazpiroben 25 mg
Number of subjects: 51
Study 34148244 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazpiroben 100 mg
Number of subjects: 51
Study 34148244 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 51
Study 32375800 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vision aids (LVAs) including video magnifier (CCTV), optical magnifier, and portable-electronic magnifier
Number of subjects: 34
Study 32375800 — intervention group
Group type: EXPERIMENTAL
Intervention: Black background
Number of subjects: 34
Study 35150433 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper body resistance exercise with low-intensity elastic bands
Number of subjects: 68
Study 35150433 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body resistance exercise with low-intensity elastic bands
Number of subjects: 68
Study 35150433 — intervention group
Group type: COMPARATOR
Intervention: Full body stretching exercise program (Control)
Number of subjects: 68
Study 33200487 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 142
Study 32597673 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-progressed digital avatars
Number of subjects: 106
Study 32597673 — intervention group
Group type: COMPARATOR
Intervention: Same-aged digital avatars
Number of subjects: 106
Study 35139654 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving Forward app (N=17)
Number of subjects: 33
Study 35139654 — intervention group
Group type: COMPARATOR
Intervention: Workbook (N=16)
Number of subjects: 33
Study 33106057 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-gravity treadmill rehabilitation
Number of subjects: 73
Study 33106057 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation protocol
Number of subjects: 73
Study 32850567 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspirational lecture and ordinary antenatal parental classes
Number of subjects: 126
Study 32850567 — intervention group
Group type: COMPARATOR
Intervention: Ordinary antenatal parental classes
Number of subjects: 126
Study 34247928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided catheterization of the brachiocephalic vein via the supraclavicular route
Number of subjects: 86
Study 34247928 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided catheterization of the internal jugular vein using the needle-out-of-plane technique
Number of subjects: 86
Study 32301670 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment on the upper eyelid
Number of subjects: 30
Study 32301670 — intervention group
Group type: COMPARATOR
Intervention: Normal IPL treatment
Number of subjects: 30
Study 35688959 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist format
Number of subjects: 2044
Study 35688959 — intervention group
Group type: EXPERIMENTAL
Intervention: Point estimates format
Number of subjects: 2044
Study 35688959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranges format
Number of subjects: 2044
Study 35688959 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual risk indicator format
Number of subjects: 2044
Study 35688959 — intervention group
Group type: COMPARATOR
Intervention: No-quantity control
Number of subjects: 2044
Study 33855877 — intervention group
Group type: EXPERIMENTAL
Intervention: CGuard carotid stent system
Number of subjects: 103
Study 32232659 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous quadratus lumborum block (QLB) with 0.25% levobupivacaine 30 ml
Number of subjects: 24
Study 32232659 — intervention group
Group type: COMPARATOR
Intervention: Continuous femoral nerve block (FNB) with 0.5% levobupivacaine 15 ml
Number of subjects: 24
Study 98049290 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolbutamide (0.74 mg. m<sup>‐2</sup>. min<sup>‐</sup> <sup>1</sup>)
Number of subjects: 0
Study 98049290 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolbutamide (elevated both peripheral and portal insulin concentrations)
Number of subjects: 0
Study 98049290 — intervention group
Group type: COMPARATOR
Intervention: Somatostatin (concurrent administration to inhibit tolbutamide-stimulated insulin secretion)
Number of subjects: 0
Study 35279270 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening spinal MRI
Number of subjects: 420
Study 35279270 — intervention group
Group type: COMPARATOR
Intervention: No MRI (control group)
Number of subjects: 420
Study 33939649 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous caffeine citrate infusion (200 mg)
Number of subjects: 65
Study 33939649 — intervention group
Group type: COMPARATOR
Intervention: Dextrose 5% in water (40 mL) (placebo)
Number of subjects: 65
Study 33939649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 65
Study 32242981 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum‐formed retainer (VFR)
Number of subjects: 60
Study 32242981 — intervention group
Group type: EXPERIMENTAL
Intervention: Hawley retainer (HR)
Number of subjects: 60
Study 32242981 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded retainer (BR)
Number of subjects: 60
Study 32242981 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 37199760 — intervention group
Group type: COMPARATOR
Intervention: Exercise in 33 °C (HEAT)
Number of subjects: 10
Study 34425873 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir (EIDD-2801/MK-4482)
Number of subjects: 10
Study 34425873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 34425873 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir (EIDD-2801/MK-4482) in fed state
Number of subjects: 10
Study 34425873 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir (EIDD-2801/MK-4482) in fasted state
Number of subjects: 10
Study 32066666 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide treatment (0.5 mg twice daily)
Number of subjects: 83
Study 32066666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bumetanide treatment)
Number of subjects: 83
Study 35738643 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (TELE‐CR)
Number of subjects: 124
Study 35738643 — intervention group
Group type: COMPARATOR
Intervention: Centre-based cardiac rehabilitation (CB‐CR)
Number of subjects: 124
Study 33011399 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of photodynamic therapy (PDT) with scaling and root planing (SRP)
Number of subjects: 45
Study 33011399 — intervention group
Group type: EXPERIMENTAL
Intervention: Two sessions of photodynamic therapy (PDT) with scaling and root planing (SRP)
Number of subjects: 45
Study 33011399 — intervention group
Group type: EXPERIMENTAL
Intervention: Three sessions of photodynamic therapy (PDT) with scaling and root planing (SRP)
Number of subjects: 45
Study 36331099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% bromfenac (BF) ophthalmic solution
Number of subjects: 19
Study 36331099 — intervention group
Group type: COMPARATOR
Intervention: 0.1% betamethasone (BM) ophthalmic solution
Number of subjects: 19
Study 32931856 — intervention group
Group type: EXPERIMENTAL
Intervention: CARPREG
Number of subjects: 100
Study 32931856 — intervention group
Group type: EXPERIMENTAL
Intervention: CARPREG II
Number of subjects: 100
Study 32931856 — intervention group
Group type: EXPERIMENTAL
Intervention: ZAHARA
Number of subjects: 100
Study 32931856 — intervention group
Group type: EXPERIMENTAL
Intervention: mWHO classification
Number of subjects: 100
Study 32729761 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patients
Number of subjects: 89
Study 32729761 — intervention group
Group type: COMPARATOR
Intervention: In-class case analyses
Number of subjects: 89
Study 36262971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal injection of autologous platelet-rich plasma (PRP)
Number of subjects: 31
Study 34876393 — intervention group
Group type: EXPERIMENTAL
Intervention: APC
Number of subjects: 68
Study 34876393 — intervention group
Group type: COMPARATOR
Intervention: MC
Number of subjects: 68
Study 35793880 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiao's scalp acupuncture combined with VR rehabilitation training
Number of subjects: 52
Study 35793880 — intervention group
Group type: COMPARATOR
Intervention: VR rehabilitation training alone
Number of subjects: 52
Study 33665812 — intervention group
Group type: EXPERIMENTAL
Intervention: sLAT (longest RVsense to LVsense activation time)
Number of subjects: 92
Study 33665812 — intervention group
Group type: EXPERIMENTAL
Intervention: pLAT (longest RVpace to LVsense activation time)
Number of subjects: 92
Study 33665812 — intervention group
Group type: COMPARATOR
Intervention: pLAT
Number of subjects: 92
Study 33665812 — intervention group
Group type: COMPARATOR
Intervention: sLAT
Number of subjects: 92
Study 32098716 — intervention group
Group type: EXPERIMENTAL
Intervention: PureVision (Bausch & Lomb)
Number of subjects: 45
Study 32098716 — intervention group
Group type: EXPERIMENTAL
Intervention: PureVision2 (Bausch & Lomb)
Number of subjects: 45
Study 35044991 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention plus short-term ART (raltegravir/emtricitabine/tenofovir)
Number of subjects: 46
Study 35044991 — intervention group
Group type: COMPARATOR
Intervention: Standard of care or behavioral intervention (not specified which)
Number of subjects: 46
Study 32907399 — intervention group
Group type: EXPERIMENTAL
Intervention: RESCUE intervention (telephone and Internet support and problem-solving)
Number of subjects: 53
Study 32907399 — intervention group
Group type: COMPARATOR
Intervention: Attention control (active listening with no advice)
Number of subjects: 53
Study 32907399 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 53
Study 32907399 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-week intervention
Number of subjects: 53
Study 32907399 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week intervention
Number of subjects: 53
Study 32907399 — intervention group
Group type: COMPARATOR
Intervention: Eight-week attention control
Number of subjects: 53
Study 35174511 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated Equia Forte Fil
Number of subjects: 32
Study 35174511 — intervention group
Group type: COMPARATOR
Intervention: Equia Forte Fil
Number of subjects: 32
Study 35174511 — intervention group
Group type: COMPARATOR
Intervention: Fuji VII EP
Number of subjects: 32
Study 35174511 — intervention group
Group type: COMPARATOR
Intervention: Beautifil II
Number of subjects: 32
Study 34844575 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) - eight 2-hour sessions
Number of subjects: 70
Study 34844575 — intervention group
Group type: COMPARATOR
Intervention: Routine interventions (Control)
Number of subjects: 70
Study 35144620 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY) 110/50 µg once daily for 8 days
Number of subjects: 31
Study 35144620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 34276344 — intervention group
Group type: EXPERIMENTAL
Intervention: treadmill gait training associated with dual task exercises+tDCS
Number of subjects: 56
Study 34276344 — intervention group
Group type: COMPARATOR
Intervention: treadmill gait training+tDCS
Number of subjects: 56
Study 34813129 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Psychosocial Screening Intervention (EPSI)
Number of subjects: 38
Study 34813129 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 38
Study 33386953 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-ZOL (6 months after last Dmab injection)
Number of subjects: 42
Study 33386953 — intervention group
Group type: EXPERIMENTAL
Intervention: Late-ZOL (18 months after last Dmab injection)
Number of subjects: 42
Study 33208696 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: 1g IV TXA administered 10 minutes before surgery and at the end of the operation
Number of subjects: 90
Study 33208696 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: 1g IV TXA administered 10 minutes before surgery
Number of subjects: 90
Study 33208696 — intervention group
Group type: COMPARATOR
Intervention: Group 3: No medication (control group)
Number of subjects: 90
Study 32362486 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 (108 CFU/day)
Number of subjects: 101
Study 32362486 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 101
Study 35169872 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy on alternate days at 33 different sites of the oral mucosa (1 J for 10 s per application point) using a low-power aluminum gallium arsenide laser device (max output power 86.7 mW, wavelength 660 nm)
Number of subjects: 36
Study 35169872 — intervention group
Group type: COMPARATOR
Intervention: SHAM group (device turned off, same protocol as PBM)
Number of subjects: 36
Study 35169872 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy
Number of subjects: 36
Study 32977252 — intervention group
Group type: EXPERIMENTAL
Intervention: EX-LGI (skim milk)
Number of subjects: 20
Study 32977252 — intervention group
Group type: EXPERIMENTAL
Intervention: EX-HGI (sports drink)
Number of subjects: 20
Study 36116481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (200 mg for bodyweight ≥5 kg to <15 kg; 300 mg for bodyweight ≥15 kg to <30 kg) every 4 weeks plus low-potency topical corticosteroids (hydrocortisone acetate 1% cream) for 16 weeks
Number of subjects: 162
Study 36116481 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus low-potency topical corticosteroids (hydrocortisone acetate 1% cream) for 16 weeks
Number of subjects: 162
Study 32264706 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (Group I)
Number of subjects: 52